How Insiders and Institutions are Trading AMAG Pharmaceuticals, Inc. (AMAG)

Recent insider trends for AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) have caught the attention of investors. Analysts monitor insider data to understand the sentiment of a company’s largest and most important shareholders. AMAG’s insider trading patterns have some implications for where the stock might be headed.

Institutions own 125.35% of AMAG Pharmaceuticals, Inc. (AMAG)’s shares. The total value of these holdings, in millions, is $805. Among active positions in the latest quarter, 90 holders increased their positions by a total of 8.77 million shares, 85 holders decreased the positions by a total of 7.2 million shares, and 25 holders held their positions. This works out to a net increase in ownership of 1.57 million shares, and suggests that institutions are feeling bullish about the stock.

Among new and sold out positions, 16 holders initiated new positions by a total of 2.46 million shares and 26 holders exited their positions by a total of 1.94 million shares. This nets out to an increase of 517114 shares and is a bullish sign for AMAG.

In the last three months, insiders executed a total of 2 trades. 2 were sells. Insider ownership decreased by a total of 2883 shares, which suggests that AMAG’s key executives are feeling less optimistic about the outlook for the stock. The data from the past twelve months tells a different story: insiders executed 15 buys and 11 sells, and ownership increased by a net of 167508 shares.

The analysis of insider buying and selling trends can be extended to the aggregate level. Short interest, which represents the number of a stock’s shares currently being shorted, captures what the market as a whole feels about a stock. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)’s short interest is 8.3 million shares, or 27.00% of the float. This represents a decrease of -2% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.

In light of the insider ownership and trading data it makes sense to consider technicals to see if they come to a similar conclusion about the outlook for AMAG. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that AMAG is a sell, which implies that AMAG is expected to underperform the market based on prior trading patterns.


Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bearish. Technical indicators (also) suggest that AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) is overvalued.

Previous ArticleNext Article

Related Post

Are Freeport-McMoRan Inc. (FCX)’s Recent Own... Recent insider trends for Freeport-McMoRan Inc. (NYSE:FCX) have caught the attention of investors. Insider data is useful because it can reveal what a...
Carnival Corporation (CCL) vs. Boyd Gaming Corpora... Carnival Corporation (NYSE:CCL) and Boyd Gaming Corporation (NYSE:BYD) are the two most active stocks in the Resorts & Casinos industry based on t...
AbbVie Inc. (ABBV): How Do the Books Stack Up? It is interesting to note that AbbVie Inc. (NYSE:ABBV) is active and made a solid movement in the last trading day. Now trading with a market value of...
What do Insider Trends Have to Say About Fang Hold... Recent insider trends for Fang Holdings Limited (NYSE:SFUN) have caught the attention of investors. Insider activity is often a strong indicator of fu...
Should You Invest in Agile Therapeutics, Inc. (AGR... Recent insider trends for Agile Therapeutics, Inc. (NASDAQ:AGRX) have caught the attention of investors. Analysts study insider data to get a sense of...